GLOL BIOE Inactive Instrument
GLOL BIOE Stock Swiss Exchange
Equities
OXGBE
FR0011052257
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| Sales 2024 * | 1.75M 1.87M | Sales 2025 * | 2.05M 2.19M | Capitalization | 30.82M 32.98M |
|---|---|---|---|---|---|
| Net income 2024 * | -6M -6.42M | Net income 2025 * | -8M -8.56M | EV / Sales 2024 * | 21.4 x |
| Net Debt 2024 * | 6.7M 7.17M | Net Debt 2025 * | 13.95M 14.93M | EV / Sales 2025 * | 21.8 x |
| P/E ratio 2024 * |
-3.09
x | P/E ratio 2025 * |
-3.18
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.03% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Marc Delcourt
FOU | Founder | 53 | 08-10-05 |
Samuel Dubruque
DFI | Director of Finance/CFO | - | 13-12-31 |
| Chief Tech/Sci/R&D Officer | - | 19-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pierre Levi
BRD | Director/Board Member | 69 | 19-04-17 |
Marc Delcourt
FOU | Founder | 53 | 08-10-05 |
| Director/Board Member | 66 | Jan. 17 |
Global Bioenergies substitutes products of fossil origin with products of natural origin. In their quest for naturalness without compromising on performance, the cosmetics players are the Company's first customers. By 2027, Global Bioenergies will be operating its innovative process in a large-scale plant. By 2030, the Company plans to become a leader in the huge emerging market for sustainable aviation fuels, in order to fight against global warming.
Calendar
2024-09-17
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +10.16% | 189B | |
| +26.21% | 150B | |
| +32.78% | 113B | |
| +1.98% | 65.05B | |
| +14.48% | 52.83B | |
| +2.92% | 49.39B | |
| -6.60% | 38.1B | |
| -1.07% | 35.14B | |
| +23.08% | 31.2B |
- Stock Market
- Equities
- ALGBE Stock
- OXGBE Stock
